January 14, 2021
Sino-foreign venture Delvigent opens feed additives plant in China
In a press statement, after three years of preparation, Delvigent has announced the opening of their new RMB100 million (~US$15.5 million; RMB1 =US$0.15) feed additives plant in China.
The first phase of the state-of-the-art factory has a capacity of 60,000 tonnes per year for the production of short and medium-chain fatty acids and essential oils as main components, with the possibility to expand to 120,000 tonnes of feed additives per year in the future. The facility is said to use only the highest quality equipment and an intelligent production management system, and was designed and built according to the strictest safety and environmental regulations.
Marcel Sengers, who has an extensive production management experience in multinational companies, has been appointed as general manager of the company.
Sengers says, "Our vision is that people all over the world will more and more demand affordable, healthy food. Our new factory enables us to execute our mission to support our customers worldwide to realise their targets on healthier animal nutrition, better performance and especially the reduction of the use of antibiotics. We chose to build our production facility in China because this means we are close to the biggest global markets for animal nutrition and have a good availability of high-quality raw materials."
The enterprise is founded by a group of international investors which all have more than 20 years of experience in animal health and feed additive solutions. "We found each other in our shared view on the need for better antimicrobial replacement solutions to have a sustainable future for agriculture," says Buis Ebbinge, one of the co-founders of the company.
Delvigent strongly believes that antibiotic replacement solutions which include products based on organic acids are the most reliable alternative when reducing antibiotics. The company has a rich experience on the successful application of such solutions, which Dr. Sam de Snoeck, another co-founder, describes as follows: "Over the last 30 years we have successfully implemented new concepts for antimicrobial replacement which are now common practice in modern animal husbandry all over the world".